이미 소장하고 있다면 판매해 보세요.
|
Volume One List of Common Acronyms Part 1 ? Introduction Chapter 1 What is radiotheranostics? Chapter 2 History of radionuclide therapy and theranostics Chapter 3 Biological principles behind targeted radionuclide therapy for cancer Part 2 ? Clinical Applications of Targeted Radionuclide Therapy in Cancer Control Chapter 4 Unconjugated radionuclides Chapter 5 Radionuclide-conjugated cancer-specific vectors: Peptides Chapter 6 Radionuclide-conjugated cancer-specific vectors: Small Molecules and antibodies Chapter 7 Radionuclide-conjugated cancer-specific vectors: Nanoparticles Chapter 8 Introduction to clinical trials and drug development for radionuclide therapies Chapter 9 Epidemiologic Studies of Cancer Risk among Patients Administered Radionuclides Chapter 10 Adverse effects of radionuclide therapy Part 3 ? Radiation Chemistry and Physics Chapter 11 Radionuclide production Chapter 12 Radioactivity measurement and traceability Chapter 13 Instrumentation, calibration, quantitative imaging, and quality control Part 4 - The Future Chapter 14 Human resources: Multidisciplinary team education, training, and competence Chapter 15 Theranostics today: Looking backwards to tomorrow Volume Two List of Common Acronyms Part 1 ? Introduction Chapter 1. Radiotheranostics: Challenges Today Part 2 ? Radiochemistry and Radiobiology Chapter 2. Radiopharmaceutical Preparations and Radiolabeling Strategies Chapter 3. New Insights Into the Radiation Biology of Radiotheranostics Chapter 4. Radiation Embryology: Human and Animal Studies Part 3 ? Particle Dosimetry Chapter 5. Alpha- and Beta-particle Therapy and Dosimetry Chapter 6. Auger Emitters Chapter 7. Positrons: Their Potential Role in Radionuclide Therapy Part 4 ? Dosimetry Formalisms Chapter 8. Biokinetic Modelling For Radionuclide Dosimetry Chapter 9. Standardized Tumor and Organ Dosimetry Chapter 10. Image-based Dosimetry Procedures Chapter 11. Combining External Beam Radiotherapy and Radionuclide Therapy Chapter 12. Uncertainties in Dose Calculations Part 5 ? Safety Chapter 13. Design, Shielding, and Operational Radiation Safety Aspects of the Radiotheranostic Facility Chapter 14. Management of Deceased Patients Under Treatment (Radioactive Cadavers) Chapter 15. Radiopharmaceutical Regulatory Requirements Part 6 ? Future Directions and Opportunities Chapter 16. The Economics of Theranostics Chapter 17. Artificial intelligence in Radiotheranostics |